Liposomes are now considered the most commonly used nanocarriers for various potentially
active hydrophobic and hydrophilic molecules due to their high biocompatibility …

Anticancer nanomedicines have been proven effective in mitigating the side effects of
chemotherapeutic drugs. However, challenges remain in augmenting their therapeutic …

Tumor immunotherapy is only effective in a fraction of patients due to a low response rate
and severe side effects, and these challenges of immunotherapy in clinics can be addressed …

Erythrocytes (red blood cells, RBCs) are the most abundant circulating cells in the blood and
have been widely used in drug delivery systems (DDS) because of their features of …

Emerging as a potent anticancer treatment, subcellular targeted cancer therapy has drawn
increasing attention, bringing great opportunities for clinical application. Here, two targeting …

Current cancer nanomedicines can only mitigate adverse effects but fail to enhance
therapeutic efficacies of anticancer drugs. Rational design of next‐generation cancer …

Photodynamic therapy (PDT) has long been recognized to be a promising approach for
cancer treatment. However, the high oxygen dependency of conventional PDT dramatically …

Precise nanomedicine has been extensively explored for efficient cancer imaging and
targeted cancer therapy, as evidenced by a few breakthroughs in their preclinical and …

Carbon quantum dots (CQDs) have emerged as a potential material in the diverse fields of
biomedical applications due to their numerous advantageous properties including …

Photothermal nanomaterials that integrate multimodal imaging and therapeutic functions
provide promising opportunities for noninvasive and targeted diagnosis and treatment in …